Stocks and Investing
Stocks and Investing
Tue, April 4, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, April 3, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Ed Arce Reiterated (UNCY) at Strong Buy and Held Target at $8 on, Apr 3rd, 2023
Ed Arce of HC Wainwright & Co., Reiterated "Unicycive Therapeutics, Inc." (UNCY) at Strong Buy and Held Target at $8 on, Apr 3rd, 2023.
Ed has made no other calls on UNCY in the last 4 months.
There are 2 other peers that have a rating on UNCY. Out of the 2 peers that are also analyzing UNCY, 0 agree with Ed's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Ed
- Elemer Piros of "EF Hutton" Reiterated at Strong Buy and Held Target at $24 on, Friday, March 31st, 2023
- Jason McCarthy of "Maxim Group" Maintained at Strong Buy with Increased Target to $6 on, Thursday, March 9th, 2023
Contributing Sources